Literature DB >> 26756386

A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases.

Brittany N Dugger1, Michael Malek-Ahmadi, Sarah E Monsell, Walter A Kukull, Bryan K Woodruff, Eric M Reiman, Thomas G Beach, Jeffrey Wilson.   

Abstract

Studies have demonstrated associations between cardiovascular factors and Alzheimer disease (AD) with minimal focus on other neurodegenerative diseases. Utilizing cross-sectional data from 17,532 individuals in the National Alzheimer's Coordinating Center, Uniform Data Set, we compared the presence of cardiovascular factors [body mass index (BMI), atrial fibrillation, hypertension, hyperlipidemia, and diabetes] in individuals carrying a diagnosis of Probable AD (ProbAD), Possible AD, vascular dementia, dementia with Lewy bodies (DLB), frontotemporal dementia, Parkinson disease, progressive supranuclear palsy, or corticobasal degeneration, with that of normals. Generalized linear mixed models were fitted with age at visit, gender, and cardiovascular factors as fixed effects and Alzheimer's Disease Centers as random effects. In late life, only BMI of ProbAD and DLB patients was statistically significantly lower than that in normals (P-values <0.001). When accounting for colinearity within cardiovascular factors, a low BMI was a comorbidity of certain dementia etiologies as compared with normals. These data support a concept of disease-specific associations with certain cardiovascular factors.

Entities:  

Mesh:

Year:  2016        PMID: 26756386      PMCID: PMC4940303          DOI: 10.1097/WAD.0000000000000138

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  38 in total

1.  Neurofibrillary pathology in the human paraventricular and supraoptic nuclei.

Authors:  C Schultz; E Ghebremedhin; H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1997-07       Impact factor: 17.088

2.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

3.  Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center.

Authors:  Lawrence S Honig; Walter Kukull; Richard Mayeux
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

4.  Olfaction in the elderly: a cross-sectional analysis comparing Parkinson's disease with controls and other disorders.

Authors:  Jonathan McKinnon; Virgilio Evidente; Erika Driver-Dunckley; Ashvini Premkumar; Joseph Hentz; Holly Shill; Marwan Sabbagh; John Caviness; Donald Connor; Charles Adler
Journal:  Int J Neurosci       Date:  2010-01       Impact factor: 2.292

Review 5.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

6.  Midlife and late-life obesity and the risk of dementia: cardiovascular health study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Oscar L Lopez; Paula Diehr; Ellen S O'Meara; W T Longstreth; José A Luchsinger
Journal:  Arch Neurol       Date:  2009-03

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort.

Authors:  Anna-Maija Tolppanen; Tiia Ngandu; Ingemar Kåreholt; Tiina Laatikainen; Minna Rusanen; Hilkka Soininen; Miia Kivipelto
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  The nature and course of olfactory deficits in Alzheimer's disease.

Authors:  M Serby; P Larson; D Kalkstein
Journal:  Am J Psychiatry       Date:  1991-03       Impact factor: 18.112

10.  Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease.

Authors:  Thomas G Beach; Chera L Maarouf; Reed G Brooks; Scophil Shirohi; Ian D Daugs; Lucia I Sue; Marwan N Sabbagh; Douglas G Walker; LihFen Lue; Alex E Roher
Journal:  BMC Geriatr       Date:  2011-01-25       Impact factor: 3.921

View more
  8 in total

1.  Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes.

Authors:  Paul K Crane; Rod L Walker; Joshua Sonnen; Laura E Gibbons; Rebecca Melrose; Jason Hassenstab; C Dirk Keene; Nadia Postupna; Thomas J Montine; Eric B Larson
Journal:  Neurobiol Aging       Date:  2016-08-01       Impact factor: 4.673

2.  Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes.

Authors:  Katherine E Irimata; Brittany N Dugger; Jeffrey R Wilson
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

3.  Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality.

Authors:  Alexander M Kulminski; Liang He; Irina Culminskaya; Yury Loika; Yelena Kernogitski; Konstantin G Arbeev; Elena Loiko; Liubov Arbeeva; Olivia Bagley; Matt Duan; Arseniy Yashkin; Fang Fang; Mikhail Kovtun; Svetlana V Ukraintseva; Deqing Wu; Anatoliy I Yashin
Journal:  PLoS Genet       Date:  2016-11-10       Impact factor: 5.917

Review 4.  Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine.

Authors:  Xinhua Zhou; Guozhen Cui; Hisa Hui Ling Tseng; Simon Ming-Yuen Lee; George Pak Heng Leung; Shun Wan Chan; Yiu Wa Kwan; Maggie Pui Man Hoi
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-23       Impact factor: 2.629

5.  Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders.

Authors:  Pei-Hao Chen; Shih-Jung Cheng; Hui-Chi Lin; Chuo-Yu Lee; Chih-Ho Chou
Journal:  Behav Neurol       Date:  2018-06-05       Impact factor: 3.342

6.  Influence of Weight Loss on Cognitive Functions: A Pilot Study of a Multidisciplinary Intervention Program for Obesity Treatment.

Authors:  Emma Chávez-Manzanera; Maura Ramírez-Flores; Michelle Duran; Mariana Torres; Mariana Ramírez; Martha Kaufer-Horwitz; Sylvana Stephano; Lizette Quiroz-Casian; Carlos Cantú-Brito; Erwin Chiquete
Journal:  Brain Sci       Date:  2022-04-17

7.  Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer's Disease: a Systematic Review and Meta-Analysis.

Authors:  Christos A Papanastasiou; Christina A Theochari; Nikos Zareifopoulos; Angelos Arfaras-Melainis; George Giannakoulas; Theodoros D Karamitsos; Leonidas Palaiodimos; George Ntaios; Konstantinos I Avgerinos; Dimitrios Kapogiannis; Damianos G Kokkinidis
Journal:  J Gen Intern Med       Date:  2021-07-09       Impact factor: 6.473

8.  Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer's Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer's Disease.

Authors:  Macrina Tortajada-Soler; Leticia Sánchez-Valdeón; Marta Blanco-Nistal; José Alberto Benítez-Andrades; Cristina Liébana-Presa; Enrique Bayón-Darkistade
Journal:  Int J Environ Res Public Health       Date:  2020-05-13       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.